Skip to content
Aperlena
Free alerts

Germany - Medicines - 35th generics tender (2/3) - Contract award notice

Original Deutschland - Arzneimittel - 35. Generikaausschreibung (2/3er) - Bekanntmachung vergebener Aufträge

Awarded Contract award

Key facts

Winner
Galenpharma GmbH; Zentiva Pharma GmbH; Aristo Pharma GmbH; Theramex Ireland Limited; Hexal AG; ratiopharm GmbH; BG ALIUD / STADAPHARM GbR; Micro Labs GmbH; BG Heumann / Heunet GbR; ROVI GmbH; Venipharm GmbH; PUREN Pharma GmbH & Co. KG; Bayer Vital GmbH; neuraxpharm Arzneimittel GmbH; Hormosan Pharma
Buyer
GWQ ServicePlus AG
Where
Germany
Procedure
Open procedure Anyone may submit a bid, in one step, with no pre-selection. Full entry Above the EU threshold A contract large enough that EU-wide rules apply and it must be published on TED. Full entry
CPV code The EU's common vocabulary for what is being bought: an eight-digit code every notice carries. Full entry
33600000 Pharmaceutical products
Original language
German
Source
via TED - Tenders Electronic Daily (Publications Office of the EU), verified 3 weeks ago
Notice number
599441-2026
Watch this tender

Bidding is closed. An award or a correction on this notice: an email when the register sees it. Log in

  1. Published
  2. Awarded pending

Summary

Machine-generated summary

GWQ ServicePlus AG has awarded contracts for the supply of finished medicinal products through active-substance-specific rebate agreements under Section 130a(8) of Book V of the German Social Code. The procedure was the 35th generics tender and was divided into substance-related specialist lots, with lots 1 to 56 open to framework agreements with up to two pharmaceutical companies and lots 57 to 102 with up to three companies. The winners are Galenpharma GmbH, Zentiva Pharma GmbH, Aristo Pharma GmbH, Theramex Ireland Limited, Hexal AG, ratiopharm GmbH, BG ALIUD / STADAPHARM GbR, Micro Labs GmbH, BG Heumann / Heunet GbR, ROVI GmbH, Venipharm GmbH, PUREN Pharma GmbH & Co. KG, Bayer Vital GmbH, neuraxpharm Arzneimittel GmbH and Hormosan Pharma.

Description

Es ist beabsichtigt, mit pharmazeutischen Unternehmen wirkstoffselektive Rabattvereinbarungen im Sinne des § 130a Abs. 8 SGB V über die Lieferung von Fertigarzneimitteln gemäß den in elektronischer Form zur Verfügung stehenden Vergabeunterlagen zu schließen. Die Vergabe ist in wirkstoffbezogene Fachlose unterteilt. Hinsichtlich der Einzelheiten wird auf die Vertragsbedingungen und die Preisblätter zu den einzelnen Fachlosen als Bestandteil der Vergabeunterlagen verwiesen. Abschluss eines Generikarabattvertrags für den o. g. Wirkstoff. Es wird eine Rahmenvereinbarung mit bis zu zwei (Fachlose 1-56, interne Kennung 001-056) bzw. bis zu drei (Fachlose 57 - 102, interne Kennung 057 - 102) pharmazeutischen Unternehmen geschlossen. Details dazu sowie zu den teilnehmenden Krankenkassen und den Vertragslaufzeiten entnehmen Sie bitte den Vergabeunterlagen.

Official source

Source: TED - Tenders Electronic Daily (Publications Office of the EU)

Always verify details on the official notice.

Last verified against TED - Tenders Electronic Daily (Publications Office of the EU) 3 weeks ago

View the official notice

More from this buyer

Full buyer profile

20 open tenders right now

Recent awards

Similar tenders

Market context

Avg. open tender · Medical equipment & pharmaceuticals
€10,063,485
9,570 open across Europe right now
Buyer track record on Aperlena
59 notices tracked · 32 awarded
€22 in awarded contracts

Never miss a tender like this

58 new notices in Medical equipment & pharmaceuticals in Germany in the last 7 days. Get an email when new ones appear. Free.

Set up my alert
Open notice

Keyboard shortcuts

Read a list without reaching for the mouse. The shortcuts stay quiet while you type in a field.

j
Next result
k
Previous result
Enter
Open the result
n
Next page
p
Previous page
c
Compare this result
s
Shortlist this result
/
Search from any page
Ctrl K
Search from any page
?
Show these shortcuts
Esc
Close

Start from a question

Browse by sector

Index

Close
Log in

Language